BioCorRx (BICX) Operating Leases (2019 - 2026)

BioCorRx has disclosed Operating Leases across 8 years of filings, most recently posting $148604.0 for Q1 2026.

• Operating Leases for Q1 2026 came in at $148604.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $148604.0 (changed 0.0% YoY), and the FY2025 annual result was $115745.0, down 27.26% from the prior year.
• Operating Leases came in at $148604.0 for Q1 2026 at BioCorRx, up from $115745.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $283307.0 in Q1 2022 to a low of $10945.0 in Q4 2023.
• The 5-year median for Operating Leases is $180441.5 (2022), against an average of $184960.1.
• Across the five-year window, Operating Leases tumbled 93.96% in 2023 and surged 1353.88% in 2024, its largest moves.
• BioCorRx's Operating Leases stood at $181328.0 in 2022, then sank by 93.96% to $10945.0 in 2023, then soared by 1353.88% to $159127.0 in 2024, then dropped by 27.26% to $115745.0 in 2025, then increased by 28.39% to $148604.0 in 2026.
• The last three Operating Leases figures came in at $148604.0 (Q1 2026), $115745.0 (Q4 2025), and $126918.0 (Q3 2025), per Business Quant data.